FDA nominee avoids answering questions on abortion pill, agency layoffs and other issues
Dr. Marty Makary's remarks echoed those of Health Secretary Robert F. Kennedy, who told lawmakers in January he wants to “study” the safety of mifepristone and a host of other long-established therapies.
Dr. Marty Makary's remarks echoed those of Health Secretary Robert F. Kennedy, who told lawmakers in January he wants to “study” the safety of mifepristone and a host of other long-established therapies. Read More
